Ozanimod and Vedolizumab as First-Line Advanced Therapies in Ulcerative Colitis.

Inflamm Bowel Dis

University Centre for Research and Development Department of Pharmaceutical Sciences, Chandigarh University Gharuan, Mohali, Punjab, India.

Published: January 2025

Download full-text PDF

Source
http://dx.doi.org/10.1093/ibd/izae315DOI Listing

Publication Analysis

Top Keywords

ozanimod vedolizumab
4
vedolizumab first-line
4
first-line advanced
4
advanced therapies
4
therapies ulcerative
4
ulcerative colitis
4
ozanimod
1
first-line
1
advanced
1
therapies
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!